287 related articles for article (PubMed ID: 24550385)
1. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.
Abu-Odeh M; Bar-Mag T; Huang H; Kim T; Salah Z; Abdeen SK; Sudol M; Reichmann D; Sidhu S; Kim PM; Aqeilan RI
J Biol Chem; 2014 Mar; 289(13):8865-80. PubMed ID: 24550385
[TBL] [Abstract][Full Text] [Related]
2. Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase.
Schuchardt BJ; Bhat V; Mikles DC; McDonald CB; Sudol M; Farooq A
Biochemistry; 2013 Dec; 52(51):9223-36. PubMed ID: 24308844
[TBL] [Abstract][Full Text] [Related]
3. Biophysical basis of the binding of WWOX tumor suppressor to WBP1 and WBP2 adaptors.
McDonald CB; Buffa L; Bar-Mag T; Salah Z; Bhat V; Mikles DC; Deegan BJ; Seldeen KL; Malhotra A; Sudol M; Aqeilan RI; Nawaz Z; Farooq A
J Mol Biol; 2012 Sep; 422(1):58-74. PubMed ID: 22634283
[TBL] [Abstract][Full Text] [Related]
4. Allostery mediates ligand binding to WWOX tumor suppressor via a conformational switch.
Schuchardt BJ; Mikles DC; Bhat V; McDonald CB; Sudol M; Farooq A
J Mol Recognit; 2015 Apr; 28(4):220-31. PubMed ID: 25703206
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy.
Salah Z; Bar-mag T; Kohn Y; Pichiorri F; Palumbo T; Melino G; Aqeilan RI
Cell Death Dis; 2013 Jan; 4(1):e480. PubMed ID: 23370280
[TBL] [Abstract][Full Text] [Related]
6. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.
Ludes-Meyers JH; Kil H; Bednarek AK; Drake J; Bedford MT; Aldaz CM
Oncogene; 2004 Jun; 23(29):5049-55. PubMed ID: 15064722
[TBL] [Abstract][Full Text] [Related]
7. WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β.
Wang HY; Juo LI; Lin YT; Hsiao M; Lin JT; Tsai CH; Tzeng YH; Chuang YC; Chang NS; Yang CN; Lu PJ
Cell Death Differ; 2012 Jun; 19(6):1049-59. PubMed ID: 22193544
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.
Farooq A
Exp Biol Med (Maywood); 2015 Mar; 240(3):361-74. PubMed ID: 25662954
[TBL] [Abstract][Full Text] [Related]
9. WW domains provide a platform for the assembly of multiprotein networks.
Ingham RJ; Colwill K; Howard C; Dettwiler S; Lim CS; Yu J; Hersi K; Raaijmakers J; Gish G; Mbamalu G; Taylor L; Yeung B; Vassilovski G; Amin M; Chen F; Matskova L; Winberg G; Ernberg I; Linding R; O'donnell P; Starostine A; Keller W; Metalnikov P; Stark C; Pawson T
Mol Cell Biol; 2005 Aug; 25(16):7092-106. PubMed ID: 16055720
[TBL] [Abstract][Full Text] [Related]
10. Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.
Li J; Liu J; Ren Y; Yang J; Liu P
Int J Biol Sci; 2014; 10(2):142-8. PubMed ID: 24520212
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.
Aqeilan RI; Palamarchuk A; Weigel RJ; Herrero JJ; Pekarsky Y; Croce CM
Cancer Res; 2004 Nov; 64(22):8256-61. PubMed ID: 15548692
[TBL] [Abstract][Full Text] [Related]
12. WW domain-containing oxidoreductase: a candidate tumor suppressor.
Chang NS; Hsu LJ; Lin YS; Lai FJ; Sheu HM
Trends Mol Med; 2007 Jan; 13(1):12-22. PubMed ID: 17142102
[TBL] [Abstract][Full Text] [Related]
13. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding.
Ferguson BW; Gao X; Zelazowski MJ; Lee J; Jeter CR; Abba MC; Aldaz CM
BMC Cancer; 2013 Dec; 13():593. PubMed ID: 24330518
[TBL] [Abstract][Full Text] [Related]
14. WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.
Abu-Odeh M; Salah Z; Herbel C; Hofmann TG; Aqeilan RI
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4716-25. PubMed ID: 25331887
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor WW domain-containing oxidoreductase modulates cell metabolism.
Abu-Remaileh M; Aqeilan RI
Exp Biol Med (Maywood); 2015 Mar; 240(3):345-50. PubMed ID: 25491415
[TBL] [Abstract][Full Text] [Related]
17. Role of WW Domain-containing Oxidoreductase WWOX in Driving T Cell Acute Lymphoblastic Leukemia Maturation.
Huang SS; Su WP; Lin HP; Kuo HL; Wei HL; Chang NS
J Biol Chem; 2016 Aug; 291(33):17319-31. PubMed ID: 27339895
[TBL] [Abstract][Full Text] [Related]
18. Recognition mechanism of p63 by the E3 ligase Itch: novel strategy in the study and inhibition of this interaction.
Bellomaria A; Barbato G; Melino G; Paci M; Melino S
Cell Cycle; 2012 Oct; 11(19):3638-48. PubMed ID: 22935697
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic Functions of Tumor Suppressor WWOX in Normal and Cancer Cells.
Abu-Remaileh M; Joy-Dodson E; Schueler-Furman O; Aqeilan RI
J Biol Chem; 2015 Dec; 290(52):30728-35. PubMed ID: 26499798
[TBL] [Abstract][Full Text] [Related]
20. WWOX: its genomics, partners, and functions.
Del Mare S; Salah Z; Aqeilan RI
J Cell Biochem; 2009 Nov; 108(4):737-45. PubMed ID: 19708029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
